ELELYSO
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
0069-0106 -
Package NDC
0069-0106-01 -
Application number
BLA022458 -
SPL ID
d7eb51c8-fe18-46f2-8d97-eaa343ec8821 -
SPL set ID
fa3cbd5d-677c-4b19-9032-d9182cb69a83 -
UNII
0R4NLX88O4 -
RxCUI
1292879 -
RxCUI
1292881
What the source publishes
- Labeler
- Pfizer Laboratories Div Pfizer Inc
- Active ingredients
- Taliglucerase alfa
- Form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Routes
- INTRAVENOUS
- Administrative status
- present-in-source-snapshot
- Marketing status
- BLA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "ELELYSO",
"splId": "d7eb51c8-fe18-46f2-8d97-eaa343ec8821",
"labels": [
{
"setId": "fa3cbd5d-677c-4b19-9032-d9182cb69a83",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=fa3cbd5d-677c-4b19-9032-d9182cb69a83",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=fa3cbd5d-677c-4b19-9032-d9182cb69a83"
}
],
"routes": [
"INTRAVENOUS"
],
"labeler": "Pfizer Laboratories Div Pfizer Inc",
"finished": true,
"packaging": [
{
"sample": false,
"description": "1 VIAL, GLASS in 1 CARTON (0069-0106-01) / 5 mL in 1 VIAL, GLASS",
"package_ndc": "0069-0106-01",
"identifierStatus": "well-formed",
"marketing_start_date": "20120501"
}
],
"productId": "0069-0106_d7eb51c8-fe18-46f2-8d97-eaa343ec8821",
"useDomain": "unknown",
"dosageForm": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",
"productNdc": "0069-0106",
"deaSchedule": null,
"genericName": "Taliglucerase alfa",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "TALIGLUCERASE ALFA",
"strength": "200 U/5mL"
}
],
"applicationNumber": "BLA022458",
"marketingCategory": "BLA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20120501",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"N0000175820",
"M0009360"
],
"unii": [
"0R4NLX88O4"
],
"rxcui": [
"1292879",
"1292881"
],
"spl_set_id": [
"fa3cbd5d-677c-4b19-9032-d9182cb69a83"
],
"pharm_class_cs": [
"Glucosylceramidase [CS]"
],
"pharm_class_epc": [
"Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC]"
],
"manufacturer_name": [
"Pfizer Laboratories Div Pfizer Inc"
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:0069-0106_d7eb51c8-fe18-46f2-8d97-eaa343ec8821"